These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15661413)

  • 1. Feasibility and limitations of comorbidity measurement in patients undergoing radical prostatectomy.
    Froehner M; Koch R; Litz RJ; Oehlschlaeger S; Hakenberg OW; Wirth MP
    Eur Urol; 2005 Feb; 47(2):190-5; discussion 195. PubMed ID: 15661413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidity is poor predictor of survival in patients undergoing radical prostatectomy after 70 years of age.
    Froehner M; Koch R; Litz RJ; Hakenberg OW; Oehlschlaeger S; Wirth MP
    Urology; 2006 Sep; 68(3):583-6. PubMed ID: 16979740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between age and comorbidity as predictors of mortality after radical prostatectomy.
    Froehner M; Koch R; Litz RJ; Hakenberg OW; Oehlschlaeger S; Wirth MP
    J Urol; 2008 May; 179(5):1823-9; discussion 1829. PubMed ID: 18355873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomy.
    Froehner M; Koch R; Litz RJ; Oehlschlaeger S; Twelker L; Hakenberg OW; Wirth MP
    Urology; 2008 Dec; 72(6):1252-7. PubMed ID: 18723211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of tumor- and comorbidity-related predictors of mortality after radical prostatectomy.
    Froehner M; Koch R; Litz RJ; Haase M; Klenk U; Oehlschlaeger S; Baretton GB; Wirth MP
    Scand J Urol Nephrol; 2005; 39(6):449-54. PubMed ID: 16303719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing comorbidity classification patterns at radical prostatectomy during a 10-year period.
    Froehner M; Garbrecht B; Hakenberg OW; Koch R; Litz RJ; Oehlschlaeger S; Twelker L; Wirth MP
    Urol Oncol; 2007; 25(1):26-31. PubMed ID: 17208135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which comorbidity classification best fits elderly candidates for radical prostatectomy?
    Froehner M; Hentschel C; Koch R; Litz RJ; Hakenberg OW; Wirth MP
    Urol Oncol; 2013 May; 31(4):461-7. PubMed ID: 21498089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the American Society of Anesthesiologists Physical Status classification with the Charlson score as predictors of survival after radical prostatectomy.
    Froehner M; Koch R; Litz R; Heller A; Oehlschlaeger S; Wirth MP
    Urology; 2003 Oct; 62(4):698-701. PubMed ID: 14550446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study.
    Siddiqui SA; Inman BA; Sengupta S; Slezak JM; Bergstralh EJ; Leibovich BC; Zincke H; Blute ML
    Cancer; 2006 Aug; 107(3):521-9. PubMed ID: 16773619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
    Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
    Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Charlson comorbidity score: a superior comorbidity assessment tool for the prostate cancer multidisciplinary meeting.
    Kastner C; Armitage J; Kimble A; Rawal J; Carter PG; Venn S
    Prostate Cancer Prostatic Dis; 2006; 9(3):270-4. PubMed ID: 16770340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing nature of high risk patients undergoing radical prostatectomy.
    Kane CJ; Presti JC; Amling CL; Aronson WJ; Terris MK; Freedland SJ;
    J Urol; 2007 Jan; 177(1):113-7. PubMed ID: 17162017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system.
    Buskirk SJ; Pisansky TM; Schild SE; Macdonald OK; Wehle MJ; Kozelsky TF; Collie AC; Ferrigni RG; Myers RP; Prussak KA; Heckman MG; Crook JE; Parker AS; Igel TC
    J Urol; 2006 Sep; 176(3):985-90. PubMed ID: 16890677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
    May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O
    J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.
    Malaeb BS; Rashid HH; Lotan Y; Khoddami SM; Shariat SF; Sagalowsky AI; McConnell JD; Roehrborn CG; Koeneman KS
    Urol Oncol; 2007; 25(4):291-7. PubMed ID: 17628294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy.
    Boorjian SA; Karnes RJ; Rangel LJ; Bergstralh EJ; Blute ML
    J Urol; 2008 Apr; 179(4):1354-60; discussion 1360-1. PubMed ID: 18289596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy).
    Tewari A; Raman JD; Chang P; Rao S; Divine G; Menon M
    Urology; 2006 Dec; 68(6):1268-74. PubMed ID: 17169648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram underestimates 10-year survival in healthy men selected for radical prostatectomy at age 70 years or older.
    Froehner M; Koch R; Litz RJ; Wirth MP
    Urology; 2009 Mar; 73(3):610-3; discussion 613-4. PubMed ID: 19167030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
    Birim O; Kappetein AP; Bogers AJ
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database.
    King CR; Freedland SJ; Terris MK; Kane CJ; Amling CL; Aronson WJ; Presti JC
    Urology; 2007 May; 69(5):921-6. PubMed ID: 17482935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.